SEC Form 4 research
| Issuer | LB PHARMACEUTICALS INC |
|---|---|
| Tickers | LBRX |
| Reporting owners | 26 |
| Officers and directors | 1 |
| Last public filing | 2026-10-13 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-13 | 2026-10-09 | Miller Joseph M | A | 200,000 | $0 | Not reported |
| 2026-10-13 | 2026-10-09 | Kozauer Susan Gani | A | 200,000 | $0 | Not reported |
| 2026-08-03 | 2026-07-30 | Deep Track Biotechnology Master Fund, Ltd., Deep Track Capital, LP, KROIN DAVID | P | 286,205 | $34.94 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.